Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2)
2024-511420-13-00Phase 2Authorised
- Sponsor
- Gentofte Hospital
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levofloxacin in community-acquired pneumonia (CAP), sponsored by Gentofte Hospital. Primary endpoint: Days alive and out of hospital at 14 days. Planned start Sep 2026; status: authorised.
02
Drugs
levofloxacin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2024-511420-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511420-13-00.